(Q78115215)

English

Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomy

scientific article published on 01 August 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

author name string

G Ahlgren

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

K Pedersen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

S Lundberg

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

G Aus

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

J Hugosson

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

P A Abrahamsson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

54

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

329-334

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

The influence of hormonal therapy on survival of men with advanced prostatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive margins after radical prostatectomy: correlation with local recurrence and distant progression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The risk of malignancy in the surgical margin at radical prostatectomy reduced almost three-fold in patients given neo-adjuvant hormone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormonal treatment before radical prostatectomy: a 3-year followup

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of pathologic findings with progression after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphologic changes induced by neoadjuvant androgen ablation may result in underdetection of positive surgical margins and capsular involvement by prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

PSA levels and the rate of positive surgical margins in radical prostatectomy specimens preceded by androgen blockade in clinical B2 (T2bNxMo) prostate cancer. The Lupron Depot Neoadjuvant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-i in formalin-fixed, paraffin-embedded prostatic cancer tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2900107-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(99)00107-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10443734%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q78115215&oldid=2078793344"